Authors:
POIKONEN P
SAARTO T
LUNDIN J
JOENSUU H
BLOMQVIST C
Citation: P. Poikonen et al., LEUKOCYTE NADIR AS A MARKER FOR CHEMOTHERAPY EFFICACY IN NODE-POSITIVE BREAST-CANCER TREATED WITH ADJUVANT CMF, European journal of cancer, 34, 1998, pp. 41-41
Citation: T. Saarto et al., THE EFFECT OF WITHDRAWAL OF ADJUVANT ANTIESTROGEN THERAPY ON PLASMA-LIPID LEVELS AND BONE-MINERAL DENSITY IN POSTMENOPAUSAL BREAST-CANCER PATIENTS, Annals of oncology, 9, 1998, pp. 28-28
Authors:
LARRAMENDY ML
MAJANDER P
SAARTO T
TENHUNEN M
CABALLIN R
ELOMAA I
KNUUTILA S
Citation: Ml. Larramendy et al., RADIATION-THERAPY FOR BREAST-CANCER AND CLONAL CHROMOSOME TRANSLOCATIONS - A FLUORESCENCE IN-SITU HYBRIDIZATION STUDY, Cancer genetics and cytogenetics, 100(1), 1998, pp. 57-62
Authors:
AUTIO P
SAARTO T
TENHUNEN M
ELOMAA I
RISTELI J
LAHTINEN T
Citation: P. Autio et al., DEMONSTRATION OF INCREASED COLLAGEN-SYNTHESIS IN IRRADIATED HUMAN SKIN IN-VIVO, British Journal of Cancer, 77(12), 1998, pp. 2331-2335
Authors:
SAARTO T
BLOMQVIST C
VALIMAKI M
MAKELA P
SARNA S
ELOMAA I
Citation: T. Saarto et al., CHEMICAL CASTRATION-INDUCED BY ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL CHEMOTHERAPY CAUSES RAPID BONE LOSS THAT IS REDUCED BY CLODRONATE - A RANDOMIZED STUDY IN PREMENOPAUSAL BREAST-CANCER PATIENTS, Journal of clinical oncology, 15(4), 1997, pp. 1341-1347
Authors:
SAARTO T
BLOMQVIST C
VALIMAKI M
MAKELA P
SARNA S
ELOMAA I
Citation: T. Saarto et al., CLODRONATE IMPROVES BONE-MINERAL DENSITY IN POSTMENOPAUSAL BREAST-CANCER PATIENTS TREATED WITH ADJUVANT ANTIESTROGENS, British Journal of Cancer, 75(4), 1997, pp. 602-605
Authors:
SAARTO T
BLOMQVIST C
RISSANEN P
AUVINEN A
ELOMAA I
Citation: T. Saarto et al., HEMATOLOGICAL TOXICITY - A MARKER OF ADJUVANT CHEMOTHERAPY EFFICACY IN STAGE-II AND STAGE-III BREAST-CANCER, British Journal of Cancer, 75(2), 1997, pp. 301-305
Authors:
SAARTO T
BLOMQVIST C
EHNHOLM C
TASKINEN MR
ELOMAA I
Citation: T. Saarto et al., ANTIATHEROGENIC EFFECTS OF ADJUVANT ANTIESTROGENS - A RANDOMIZED TRIAL COMPARING THE EFFECTS OF TAMOXIFEN AND TOREMIFENE ON PLASMA-LIPID LEVELS IN POSTMENOPAUSAL WOMEN WITH NODE-POSITIVE BREAST-CANCER, Journal of clinical oncology, 14(2), 1996, pp. 429-433
Authors:
SAARTO T
BLOMQVIST C
EHNHOLM C
TASKINEN MR
ELOMAA I
Citation: T. Saarto et al., EFFECTS OF CHEMOTHERAPY-INDUCED CASTRATION ON SERUM-LIPIDS AND APOPROTEINS IN PREMENOPAUSAL WOMEN WITH NODE-POSITIVE BREAST-CANCER, The Journal of clinical endocrinology and metabolism, 81(12), 1996, pp. 4453-4457
Authors:
SAARTO T
BLOMQVIST C
VALIMAKI M
MAKELA P
ELOMAA I
Citation: T. Saarto et al., CLODRONATE IMPROVES BONE-MINERAL DENSITY IN EARLY BREAST-CANCER PATIENTS - A RANDOMIZED STUDY, European journal of cancer, 31A, 1995, pp. 51-51
Citation: T. Saarto et al., CORRELATION BETWEEN DOSE INTENSITY, HEMATOLOGICAL TOXICITY AND OUTCOME OF ADJUVANT CHEMOTHERAPY IN BREAST-CANCER, European journal of cancer, 31A, 1995, pp. 64-64
Authors:
SAARTO T
BLOMQVIST C
EHNHOLM C
TASKINEN MR
ELOMAA I
Citation: T. Saarto et al., THE EFFECTS OF TAMOXIFEN AND TOREMIFENE ON PLASMA-LIPID LEVELS IN POSTMENOPAUSAL EARLY BREAST-CANCER PATIENTS, European journal of cancer, 31A, 1995, pp. 65-65